Group One Trading, L.P. Mustang Bio, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.35 - $0.72 $2,123 - $4,367	-6,066 Reduced 38.79%	9,574 $3,000
Q2 2022 Aug 11, 2022	SELL	$0.58 - $1.13 $6,090 - $11,864	-10,500 Reduced 40.17%	15,640 $9,000
Q1 2022 May 12, 2022	SELL	$0.73 - $1.81 $4,745 - $11,765	-6,500 Reduced 19.91%	26,140 $26,000
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $8,942 - $14,221	5,387 Added 19.77%	32,640 $54,000
Q3 2021 Nov 12, 2021	BUY	$2.58 - $3.36 $70,312 - $91,570	27,253 New	27,253 $73,000
Q1 2021 May 12, 2021	SELL	$3.02 - $5.16 $65,259 - $111,502	-21,609 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.66 - $4.18 $14,696 - $23,094	5,525 Added 34.35%	21,609 $82,000
Q3 2020 Nov 12, 2020	BUY	$3.01 - $3.88 $18,312 - $23,605	6,084 Added 60.84%	16,084 $51,000
Q2 2020 Aug 13, 2020	BUY	$2.33 - $4.6 $23,300 - $46,000	10,000 New	10,000 $32,000
Q3 2019 Nov 12, 2019	SELL	$2.74 - $4.65 $13,447 - $22,822	-4,908 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$2.66 - $6.28 $13,055 - $30,822	4,908 New	4,908 $18,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $17.9M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.